" class="no-js "lang="en-US"> David A. Sinclair A.O., Ph.D. - Medtech Alert
Monday, February 26, 2024
David A. Sinclair A.O., Ph.D | MTA

David A. Sinclair A.O., Ph.D.

About David A. Sinclair A.O., Ph.D.

David A. Sinclair, A.O. Ph.D. is a tenured Professor in the Genetics Department at Harvard Medical School, Boston & Co-Director of the Paul F. Glenn Center for Biology of Aging Research, honorary Professor at the University of Sydney, and co-founder of the journal Aging. He obtained a B.S. and a Ph.D. at UNSW, worked as a postdoctoral researcher at M.I.T., was hired at Harvard Medical School in 1999 as an Assistant Professor, and was promoted to tenured Professor in 2008. His book Lifespan: Why We Age and Why We Don't Have To, an NYT bestseller, is published in more than 20 languages. In 2022, Dr. Sinclair launched the Lifespan Podcast with co-host Matthew D. LaPlante. Dr. Sinclair is an inventor on more than 50 patents, 170 papers, an h-index of 113 & cited 85,000+ times. His more than 40 awards include an Excellence in Teaching Award, Harvard, AFAR Fellowship, the Ellison Medical Foundation Scholarships, Genzyme Outstanding Achievement Award, Telluride Technology Award, Innovator of the Year, MERIT Award, Nathan Shock Award, Denham Harman Award, ASMR Medal, Advance Global Australian, Pioneer Award, TIME100's most influential people, TIME magazine's Healthcare 50, Irving Wright Award, AFAR, and is an Officer of the Order of Australia (A.O.). He co-founded Sirtris Pharma (Cambridge; NASDAQ: SIRT, bought by G.S.K.), Genocea (Cambridge, MA; NASDAQ: GNCA); Ovascience (NASDAQ: OVAS), Cohbar (Menlo Park NASDAQ: CWBR)), MetroBiotech, ArcBio, Liberty Biosecurity, Galilei, Immetas, EdenRoc Sciences and affiliates, and Life Biosciences and affiliates. David Sinclair is a founder, equity owner, advisor to, director of, and/or inventor of patents licensed to Metrobiotech, Jumpstart Fertility, Liberty Biosecurity, Animal Biosciences, EdenRoc Sciences, Life Biosciences, Cohbar, Galilei, Spotlight Biosciences, Arc-Bio, Dovetail Genomics, Claret Bio, Selphagy, Iduna, Senolytic Therapeutics, Tally Health, Fully Aligned Co, Continuum, Immetas and a licensed unpaid H.M.S. patent to Elysium Health.

Related Story

Life Biosciences Presents Groundbreaking Data at ARVO Demonstrating Restoration of Visual Function in Nonhuman Primates

April 24 2023

Life Biosciences (Life Bio), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases […]

Related People

David A. Sinclair A.O., Ph.D.

David A. Sinclair A.O., Ph.D.

Related Company

Life Biosciences